422 related articles for article (PubMed ID: 26750803)
21. Commissioning of Helium Ion Therapy and the First Patient Treatment With Active Beam Delivery.
Tessonnier T; Ecker S; Besuglow J; Naumann J; Mein S; Longarino FK; Ellerbrock M; Ackermann B; Winter M; Brons S; Qubala A; Haberer T; Debus J; Jäkel O; Mairani A
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):935-948. PubMed ID: 36681200
[TBL] [Abstract][Full Text] [Related]
22. Comparing proton treatment plans of pediatric brain tumors in two pencil beam scanning nozzles with different spot sizes.
Kralik JC; Xi L; Solberg TD; Simone CB; Lin L
J Appl Clin Med Phys; 2015 Nov; 16(6):41-50. PubMed ID: 26699553
[TBL] [Abstract][Full Text] [Related]
23. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
[TBL] [Abstract][Full Text] [Related]
24. Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis.
Widesott L; Pierelli A; Fiorino C; Lomax AJ; Amichetti M; Cozzarini C; Soukup M; Schneider R; Hug E; Di Muzio N; Calandrino R; Schwarz M
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1589-600. PubMed ID: 21167651
[TBL] [Abstract][Full Text] [Related]
25. Can differences in linear energy transfer and thus relative biological effectiveness compromise the dosimetric advantage of intensity-modulated proton therapy as compared to passively scattered proton therapy?
Giantsoudi D; Adams J; MacDonald S; Paganetti H
Acta Oncol; 2018 Sep; 57(9):1259-1264. PubMed ID: 29726722
[TBL] [Abstract][Full Text] [Related]
26. Impact of respiratory motion on variable relative biological effectiveness in 4D-dose distributions of proton therapy.
Ulrich S; Wieser HP; Cao W; Mohan R; Bangert M
Acta Oncol; 2017 Nov; 56(11):1420-1427. PubMed ID: 28828913
[TBL] [Abstract][Full Text] [Related]
27. Introducing Proton Track-End Objectives in Intensity Modulated Proton Therapy Optimization to Reduce Linear Energy Transfer and Relative Biological Effectiveness in Critical Structures.
Traneus E; Ödén J
Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):747-757. PubMed ID: 30395906
[TBL] [Abstract][Full Text] [Related]
28. Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy.
Koeck J; Abo-Madyan Y; Lohr F; Stieler F; Kriz J; Mueller RP; Wenz F; Eich HT
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):268-76. PubMed ID: 22079733
[TBL] [Abstract][Full Text] [Related]
29. Biological dose and complication probabilities for the rectum and bladder based on linear energy transfer distributions in spot scanning proton therapy of prostate cancer.
Pedersen J; Petersen JBB; Stokkevåg CH; Ytre-Hauge KS; Flampouri S; Li Z; Mendenhall N; Muren LP
Acta Oncol; 2017 Nov; 56(11):1413-1419. PubMed ID: 29037095
[TBL] [Abstract][Full Text] [Related]
30. Hydrogel rectum-prostate spacers mitigate the uncertainties in proton relative biological effectiveness associated with anterior-oblique beams.
Underwood TS; Voog JC; Moteabbed M; Tang S; Soffen E; Cahlon O; Lu HM; Zietman AL; Efstathiou JA; Paganetti H
Acta Oncol; 2017 Apr; 56(4):575-581. PubMed ID: 28075206
[TBL] [Abstract][Full Text] [Related]
31. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study.
Weber DC; Bogner J; Verwey J; Georg D; Dieckmann K; Escudé L; Caro M; Pötter R; Goitein G; Lomax AJ; Miralbell R
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):373-84. PubMed ID: 16168832
[TBL] [Abstract][Full Text] [Related]
32. Dose to the developing dentition during therapeutic irradiation: organ at risk determination and clinical implications.
Thompson RF; Schneider RA; Albertini F; Lomax AJ; Ares C; Goitein G; Hug EB
Int J Radiat Oncol Biol Phys; 2013 May; 86(1):108-13. PubMed ID: 23332385
[TBL] [Abstract][Full Text] [Related]
33. A treatment planning comparison of intensity modulated photon and proton therapy for paraspinal sarcomas.
Weber DC; Trofimov AV; Delaney TF; Bortfeld T
Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1596-606. PubMed ID: 15050341
[TBL] [Abstract][Full Text] [Related]
34. Relating the proton relative biological effectiveness to tumor control and normal tissue complication probabilities assuming interpatient variability in α/β.
Paganetti H
Acta Oncol; 2017 Nov; 56(11):1379-1386. PubMed ID: 28918679
[TBL] [Abstract][Full Text] [Related]
35. Advantage of proton-radiotherapy for pediatric patients and adolescents with Hodgkin's disease.
Lautenschlaeger S; Iancu G; Flatten V; Baumann K; Thiemer M; Dumke C; Zink K; Hauswald H; Vordermark D; Mauz-Körholz C; Engenhart-Cabillic R; Eberle F
Radiat Oncol; 2019 Sep; 14(1):157. PubMed ID: 31477141
[TBL] [Abstract][Full Text] [Related]
36. Harmonization of proton treatment planning for head and neck cancer using pencil beam scanning: first report of the IPACS collaboration group.
Stock M; Gora J; Perpar A; Georg P; Lehde A; Kragl G; Hug E; Vondracek V; Kubes J; Poulova Z; Algranati C; Cianchetti M; Schwarz M; Amichetti M; Kajdrowicz T; Kopeć R; Mierzwińska G; Olko P; Skowrońska K; Sowa U; Góra E; Kisielewicz K; Sas-Korczyńska B; Skóra T; Bäck A; Gustafsson M; Sooaru M; Witt Nyström P; Nyman J; Björk Eriksson T
Acta Oncol; 2019 Dec; 58(12):1720-1730. PubMed ID: 31393203
[No Abstract] [Full Text] [Related]
37. Towards proton arc therapy: physical and biologically equivalent doses with increasing number of beams in pediatric brain irradiation.
Toussaint L; Indelicato DJ; Holgersen KS; Petersen JBB; Stokkevåg CH; Lassen-Ramshad Y; Casares-Magaz O; Vestergaard A; Muren LP
Acta Oncol; 2019 Oct; 58(10):1451-1456. PubMed ID: 31303090
[No Abstract] [Full Text] [Related]
38. Incorporating variable RBE in IMPT optimization for ependymoma.
Goudarzi HM; Lim G; Grosshans D; Mohan R; Cao W
J Appl Clin Med Phys; 2024 Jan; 25(1):e14207. PubMed ID: 37985962
[TBL] [Abstract][Full Text] [Related]
39. Significance and implementation of RBE variations in proton beam therapy.
Paganetti H
Technol Cancer Res Treat; 2003 Oct; 2(5):413-26. PubMed ID: 14529306
[TBL] [Abstract][Full Text] [Related]
40. Contour-based lung dose prediction for breast proton therapy.
Zeng C; Sine K; Mah D
J Appl Clin Med Phys; 2018 Nov; 19(6):53-59. PubMed ID: 30141230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
